New York State Common Retirement Fund’s Travere Therapeutics TVTX Stock Holding History

New York State Common Retirement Fund’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.72M	Buy	293,357 +43,800	+18%	+$1.31M	0.01%	789
2025 Q4	$9.54M	Buy	249,557 +221,743	+797%	+$7.21M	0.01%	755
2025 Q3	$665K	Hold	27,814	–	–	﹤0.01%	1839
2025 Q2	$412K	Buy	27,814 +4,900	+21%	+$81.2K	﹤0.01%	1974
2025 Q1	$411K	Hold	22,914	–	–	﹤0.01%	1947
2024 Q4	$399K	Hold	22,914	–	–	﹤0.01%	2019
2024 Q3	$321K	Sell	22,914 -2,700	-11%	-$28.1K	﹤0.01%	2103
2024 Q2	$211K	Buy	25,614 +23	+0.1%	+$155	﹤0.01%	2402
2024 Q1	$197K	Sell	25,591 -71	-0.3%	-$599	﹤0.01%	2451
2023 Q4	$231K	Sell	25,662 -106	-0.4%	-$772	﹤0.01%	2395
2023 Q3	$230K	Sell	25,768 -27,103	-51%	-$382K	﹤0.01%	2363
2023 Q2	$812K	Sell	52,871 -6,860	-11%	-$125K	﹤0.01%	1871
2023 Q1	$1.34M	Buy	59,731 +1,780	+3%	+$37.8K	﹤0.01%	1740
2022 Q4	$1.22M	Sell	57,951 -26	-0%	-$551	﹤0.01%	1869
2022 Q3	$1.43M	Buy	57,977 +14,759	+34%	+$381K	﹤0.01%	1779
2022 Q2	$1.05M	Sell	43,218 -121	-0.3%	-$3.04K	﹤0.01%	1991
2022 Q1	$1.12M	Buy	43,339 +55	+0.1%	+$1.46K	﹤0.01%	2055
2021 Q4	$1.34M	Buy	43,284 +3,945	+10%	+$111K	﹤0.01%	1984
2021 Q3	$954K	Sell	39,339 -11,315	-22%	-$208K	﹤0.01%	2132
2021 Q2	$739K	Buy	50,654 +4,354	+9%	+$85.9K	﹤0.01%	2374
2021 Q1	$1.16M	Hold	46,300	–	–	﹤0.01%	2063
2020 Q4	$1.26M	Buy	46,300 +5,500	+13%	+$128K	﹤0.01%	1931
2020 Q3	$753K	Hold	40,800	–	–	﹤0.01%	2037
2020 Q2	$833K	Buy	40,800 +5,100	+14%	+$81.2K	﹤0.01%	1963
2020 Q1	$521K	Hold	35,700	–	–	﹤0.01%	2011
2019 Q4	$507K	Sell	35,700 -9,000	-20%	-$115K	﹤0.01%	2297
2019 Q3	$518K	Hold	44,700	–	–	﹤0.01%	2313
2019 Q2	$898K	Buy	44,700 +5,000	+13%	+$98.7K	﹤0.01%	2072
2019 Q1	$898K	Hold	39,700	–	–	﹤0.01%	2018
2018 Q4	$898K	Sell	39,700 -4,800	-11%	-$119K	﹤0.01%	1976
2018 Q3	$1.28M	Hold	44,500	–	–	﹤0.01%	1952
2018 Q2	$1.21M	Hold	44,500	–	–	﹤0.01%	1998
2018 Q1	$995K	Buy	44,500 +3,600	+9%	+$85.7K	﹤0.01%	2029
2017 Q4	$862K	Hold	40,900	–	–	﹤0.01%	2116
2017 Q3	$1.02M	Hold	40,900	–	–	﹤0.01%	1994
2017 Q2	$793K	Sell	40,900 -1	-0%	-$18	﹤0.01%	2182
2017 Q1	$755K	Buy	40,901 +1	+0%	+$20	﹤0.01%	2181
2016 Q4	$774K	Hold	40,900	–	–	﹤0.01%	2173
2016 Q3	$915K	Buy	40,900 +6,900	+20%	+$131K	﹤0.01%	2038
2016 Q2	$606K	Hold	34,000	–	–	﹤0.01%	2204
2016 Q1	$464K	Hold	34,000	–	–	﹤0.01%	2284
2015 Q4	$656K	Hold	34,000	–	–	﹤0.01%	2186
2015 Q3	$689K	Buy	34,000 +689	+2%	+$20.4K	﹤0.01%	2162
2015 Q2	$1.1M	Buy	+33,311	New	+$912K	﹤0.01%	2121

Other funds holding TVTX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund's TVTX Position: Q1 2026 in Review

New York State Common Retirement Fund increased its Travere Therapeutics (TVTX) stake by 18% in Q1 2026, buying an estimated $1.31M and bringing the position to 293,357 shares worth $8.72M. The position accounts for 0.01% of the portfolio, ranked #789.

New York State Common Retirement Fund first reported a position in TVTX in Q2 2015 and has held it in 44 quarters since. The position peaked at $9.54M in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

New York State Common Retirement Fund held 293,357 shares of Travere Therapeutics worth $8.72M as of Q1 2026.
New York State Common Retirement Fund bought 43,800 Travere Therapeutics shares in Q1 2026, an estimated $1.31M.
Travere Therapeutics made up 0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #789 holding.
New York State Common Retirement Fund first reported a position in Travere Therapeutics in Q2 2015 and has held it in 44 quarters since.
New York State Common Retirement Fund's Travere Therapeutics position peaked at $9.54M in Q4 2025.
260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.